tsl and ts7, the paralytogenic, temperature-sensitive mutants of Moloney murine leukemia virus (MoMuLV), together with their wild-type parent, MoMuLV-TB, were molecularly cloned. tsl-19, ts7-22, and wt-25, the infectious viruses obtained on transfection to NIH/3T3 cells of the lambda Charon 21A recombinants of tsl, ts7, and wt, were found to have retained the characteristics of their non-molecularly cloned parents. In contrast to the wt virus, tsl-19 and ts7-22 are temperature-sensitive, inefficient in the intracellular processing of Pr8Oe"v at the restrictive temperature, and able to induce paralysis in CFW/D mice. Like the non-molecularly cloned ts7, the ts7-22 virion was also shown to be heat labile. The heat lability of the ts7 virion distinguishes it from tsl. Endonuclease restriction mapping with 11 endonucleases demonstrated that the base composition of MoMuLV-TB differs from that of the standard MoMuLV, but no difference was detected between the molecularly cloned tsl and ts7 genomes. However, tsl and ts7 differ from MoMuLV in the loss or acquisition of four different restriction sites, whereas they differ from MoMuLV-TB in the loss or acquisition of three different restriction sites.
Both spontaneous and bromodeoxyuridine-induced temperature-sensitive (ts) mutants have been isolated from MoMuLV-TB, a strain of Moloney murine leukemia virus (MoMuLV) (8, 15, 16) . A group of these ts mutants, tsl, ts7, and tsll, each of which was isolated on a separate occasion, was shown to be capable of inducing a rapidly fatal lower motor-neuron disease on inoculation into neonates of susceptible strains of mice such as CFW/D and BALB/c (5, 17) . The pathogenicity induced by this group of mutants therefore differs strikingly from that of the T-cell lymphomas induced by the parental wild-type (wt) MoMuLV-TB. Furthermore, another ts mutant of MoMuLV-TB, ts3, which is characterized by a different phenotype from that of tsl, ts7, and tsll, failed to induce hind-limb paralysis in these susceptible strains of mice. These findings suggest that the ability of tsl, ts7, and tsll to induce hind-limb paralysis may be due to a specific alteration of the viral genome and is not a common characteristic of all ts mutants of MoMuLV.
Biochemical studies (17) showed that at the restrictive temperature (39°C) these paralytogenic mutants are all defective in the processing of the envelope precursor protein Pr80en"', so that this protein accumulates in the infected cells.
Furthermore, the inefficient processing of Pr80e"' in the mutant-infected cells at the restrictive temperature can be reversed by shifting the culture to the permissive temperature (34°C). In contrast, the rnonparalytogenic mutant, ts3, like the wt virus, shows normal processing of Pr80en" in infected cells at 39°C.
Whether inefficiency in the processing of Pr80e"l' and the ability to induce paralysis results from the same mutation or two different and unrelated mutations has not been determined. In addition, whether the accumulation of Pr80en" in the infected cells plays a role in the induction of paralysis remains to be investigated.
As a first step in identifying the change(s) in the tsl and ts7 genomes which confer on them temperature sensitivity, inefficiency in the processing of Pr80e?l, and the ability to induce paralysis, tsl, ts7, and MoMuLV-TB were molecularly cloned into lambda Charon 21A, and the cloned genomes were characterized.
MATERIALS AND METHODS
Cells. Viruses were propagated in mouse TB cells, an established tissue culture cell line derived from mixed culture of thymus and bone marrow from CFW/D mice (1) , and assayed on 15F cells (19) . NIH/3T3 cells were used for transfection experiments. All cell lines were maintained in Dulbecco modified Eagle minimum supplemented with 8% fetal calf serum.
Viruses and virus assay. The strain used in this study (MoMuLV-TB) was isolated as described by Wong et al. (16) tsl and ts7 are both spontaneous ts mutants of MoMuLV-TB that were isolated as described by Wong et al. (15, 16) . They were isolated on separate occasions. The tsl used in the present studies was also recently clonally purified. ts7, however, was not recently single-virus-single-cell cloned before its cloning into lambda Charon 21A. The 15F assay for MuLV has been described previously (18) . (Fig. 1) . The infectivity of wt-25 and tsl-19 decreased only about fivefold in 3 h on incubation at 39°C, whereas the infectivity of ts7-22 decreased by more than 2,000-fold over the 3-h period.
Processing of Pr8MOev in infected cells. We have previously demonstrated (17) that the paralytogenic ts mutants tsl, ts7, and tsll are inefficient in the processing of Pr8eO"' at the restrictive temperature. The infectious virus-producing NIH/3T3 cell cultures obtained by transfecting molecularly cloned tsl-19, ts7-22, and wt-25 DNAs were therefore processed to determine the efficiency of the intracellular processing of Pr8Oen'.
Although the processing of PrOg"' appears normal, the processing of Pr8MeOl' in tsl-19 transfected cells grown at the restrictive temperature is greatly retarded when compared with the processing of Pr80eM ' in wt-25 transfected cells during the 3-h chase period (Fig. 2) . The pattern of processing of Pr8eh"' in ts7-22 transfected cells is similar to that of tsl-19, and the data are therefore not shown.
Ability a The supernatant of the infectious virus producing tsl-19, is7-22, or wt-25 DNA transfected cultures grown at 34°C was adsorbed onto 15F cells at 34°C for 45 min, then incubated at the permissive (34°C) and restrictive (39°C) temperatures. The 15F assay for virus infectivity was done as described previously (18) . Table 2 . Every mouse injected with the non-molecularly cloned tsl and ts7 DNAs became paralyzed. Although the latent period for both the non-molecularly cloned tsl virus and the molecularly cloned tsl-19 virus ranged from 20 to 90 days post-injection, about 78 and 63%, respectively, of the mice injected with these viruses became paralyzed by 40 days post-injection (Fig. 3) . By 60 days post-injection, over 80% of the mice had become paralyzed. Although the latent period for both the non-molecularly cloned ts7 virus and the molecularly cloned ts7-22 virus ranged from 20 to 80 days post-injection, for both of these viruses there appears to be a more protracted latent period. Over 60% of the 30 mice injected with the non-molecularly cloned ts7 virus became paralyzed from 40 to 60 days post-injection. In the case of the molecularly cloned ts7-22 virus, for which only 16 mice were tested, although about 30% of the mice became paralyzed for 40 days post-injection, the majority became paralyzed from 50 to 80 days post-injection. In contrast, mice injected with the non-molecularly cloned MoMuLV-TB virus and the cloned wt-25 virus were not paralyzed ( Table 2 ). These mice lived for at least 190 days after inoculation with either of these viruses. These studies clearly showed that the ability to induce paralysis is genetically determined and is due to mutation(s) in the tsl and ts7 genomes. (Fig. 6 ). To confirm this possibility, the HindIII-PstI DNA fragment of tsl-19 was digested with both XbaI and PvuII. As predicted from the nucleotide sequence of MoMuLV and confirmed in the present study, PvuII restriction of the HindIII-PstI DNA fragment of MoMuLV, MoMuLV-TB, and tsl-19 generated four fragments of about 2.8, 0.8, 0.2, and 0.1 kbp. Only the two larger fragments are visible in Fig. 4C, lanes 1 Fig. 4C , lanes 7 through 9.
The above studies showed that the HindIII-PstI DNA segments of both the MoMuLV-TB and tsl genomes differ from that of MoMuLV in the loss of the XbaI site at nucleotide 5325. In addition, the HindIII-PstI segment of the tsl genome has lost the XbaI site present at nucleotide 8113 in both of the wt genomes.
The HindIII-PstI segment of the molecularly cloned infectious DNA of tsl-20, another Charon 21A tsl recombinant obtained in a separate cloning experiment, and ts7-22 were isolated and digested with the same endoniiclease restriction enzymes. The endonuclease restriction map of the HindIllPstI genomic fragments of tsl-20 and ts7-22 cannot be distinguished from that of tsl-19 (data not shown).
Results of the endonuclease digests of the KpnI-KpnI genomic sequences of MoMuLV, MoMuLV-TB, and tsl from nucleotide 37-2862 and the KpnI-HindIII sequences from nucleotide 2863-4894 are shown in Fig. SA Figure 5A, lane 2 shows the expected 1.9-and 1.0-kbp bands on BglII cleavage of the KpnI-KpnI fragment of MoMuLV at nucleotide 1906. In contrast, the homologous DNA segments of both tsl and MoMuLV-TB were not cleaved by BglII (lanes 4 and 6) .
No BamHI site was found in the KpnI-KpnI DNA segments of MoMuLV (Fig. 5B, lane 2) and MoMuLV-TB (Fig.  SB, lane 4) . In contrast, the homologous tsl DNA was cleaved once, generating two fragments of approximately 2.2 and 0.6 kbp (Fig. 5B, lane 6) . To locate the BamHI site in the tsl DNA, the KpnI-KpnI tsl DNA segment was digested with both BamHI and PstI. Figure 5D , lane 2, shows the expected ca. 2.1-and 0.5-kbp fragments on PstI digestion (the small 0.2-kbp PstI-PstI fragment is not visible on the ethidium bromide-stained gel). On cleavage with BamHI and PstI, the 0.5-kbp fragment remains present, but the ca. 2.3-kbp fragment is further cleaved, generating two fragments of approximately 1.5 and 0.6 kbp (lane 4), thus locating the BamHI site at about 0.6 kb from the 3' end of the KpnI-KpnI tsl DNA segment.
Examination of the nucleotide sequence of MoMuLV at about 0.6 bp upstream from the KpnI site at nucleotide 2863 showed that, beginning at nucleotide 2355, there is a sequence GGACCC and, beginning at nucleotide 2380, there is another sequence GGGTCC (11) . A single-base substitution in either sequence will generate a BamHI site. In both cases, although the amino acid residue will be changed there is no disruption of the reading frame. We have therefore tentatively assigned the BamHI site to either of these two sites.
On XhoI digestion, the KpnI-HindIII segment of MoMuLV-TB is cleaved (Fig. SB, lane 11) , which is in contrast to the absence of an XhoI site in both MoMuLV (Fig. SB, lane 9) and tsl (Fig. SB, lane 13) . To locate the XhoI site in the MoMuLV-TB DNA, the KpnI-HindIII DNA segment was doubly digested with XhoI and Sall. Restriction with Sall generated the expected two fragments of approximately 1.2 and 0.8 kbp (Fig. 5D, lane 6) , since the Sall site is located at about 0.8 kbp from the KpnI site. On restriction with XhoI and Sall simultaneously, the smaller (0.8-kbp) fragment was further cleaved to yield two very similar-sized fragments of about 0.4 kbp (Fig. SD, lane 7) , indicating that the XhoI site is located about 0.4 kbp from the KpnI site. The other k recombinant DNAs of MoMuLV-TB Xwt-14 and Xwt-17 were also restricted with XhoI, and both were found to possess the additional XhoI site in the KpnI-HindIII segment of the pol gene. Examination of the nucleotide sequence of MoMuLV (11) the Kpnl site showed that, beginning at nucleotide 3316 and 3345, there is a sequence CTCGGG which is an AvaI recognition site. Substituting the G residue at nucleotide 3320 or 3349 with an A residue will generate an XhoI recognition site while retaining the AvaI recognition site. We have therefore tentatively assigned the XhoI site to one of the Av'aI sites (Fig. 6 ). In the first case, no change in amino acid sequence will result; in the second case, a codon for glycine becomes a codon for glutamic acid.
The KpnI-KpnI and KpnI-HindIII segments of the molecularly cloned DNA of tsl-20 and ts7-22 were isolated and similarly endonuclease restriction mapped. The infectious VOL. 54, 1985 The restriction maps of the molecularly cloned DNAs of wt-8.2, wt-25, tsl-19, and ts7-22 of standard MoMuLV, MoMuLV-TB, tsl, and ts7, respectively, are schematically presented in Fig. 6 .
DISCUSSION
To identify the change(s) in the genome which confers on tsl and ts7 the temperature sensitivity, inefficiency in the processing of Pr80e"v, and the ability to induce hind-limb paralysis, we have molecularly cloned tsl, ts7, and MoMuLV-TB. The infectious viruses obtained on transfection of the molecularly cloned tsl-19, ts7-22, and wt-25 DNAs into NIH/3T3 cells were found to have retained the characteristics of their non-molecularly cloned parents.
Endonuclease restriction mapping with 11 endonucleases demonstrated that the base composition of MoMuLV-TB differs from that of MoMuLV (Fig. 6) . It has been reported by Shields et al. (10) and confirmed by us (unpublished data) that the electrophoretic mobility of MoMuLV-TB p30 differs from that of MoMuLV. We have also found that the p30 of tsl and ts7 has the same electrophoretic mobility as the p30 of MoMuLV-TB (17) . The BglII site present at nucleotide 1905 at the 5' end of the p30 coding sequence of MoMuLV is absent in the MoMuLV-TB, tsl, and ts7 genomes. This finding clearly shows that this segment of the genome is mutated. However, whether the mutation at the BglII site in the MoMuLV-TB, tsl, and ts7 genomes is responsible for the difference in electrophoretic mobility of p30 remains to be investigated.
Another characteristic that distinguishes standard MoMuLV from MoMuLV-TB is the relatively longer latent period before mice infected with MoMuLV-TB die from lymphoma (5) Whether the effects of these and other presently undetermined differences on the potency of the virus in the induction of lymphoma are significant remains to be investigated. The differences further emphasize that MoMuLV-TB has diverged from MoMuLV.
Endonuclease restriction maps of tsl and ts7 obtained with 11 enzymes were similar. This is not altogether unexpected. Despite the fact that tsl and ts7 were isolated on separate occasions, they share certain common characteristics. However, they are distinguishable in that mice infected with ts7 need a slightly longer latent period before developing paralysis than those infected with tsl ( Fig. 3) and that the virions of ts7 are more heat labile than those of tsl (Fig. 1) . A more detailed analysis of these genomes is now in progress to identify the base change(s) which confers on ts7 virions heat lability and the attenuated ability to induce paralysis. tsl and ts7 differ from MoMuLV in the loss or acquisition of four different restriction sites, whereas tsl and ts7 differ from MoMuLV-TB in the loss or acquisition of three different restriction sites. However, only two changes are peculiar to tsl and ts7 and not shared with either of the wt genomes. These are the loss of the XbaI site at nucleotide 8113 and the presence of an additional BamHI site at the 5' end of the pol coding sequence (Fig. 6 ). This finding is unexpected, since studies reported elsewhere (Yuen et progress to determine by exchanging genomic fragments within the HindIII-BamHI sequence and nucleotide sequencing whether the ts function, the inefficiency in the processing of Pr80efV, and the ability to induce paralysis result from a single mutation or multiple mutations.
